Spineart USA INC
Reporting payments is a legal requirement; large totals often reflect large product portfolios.
$5.1Mgeneral payments (2019-2025)
$584Kresearch payments (2019-2025)
642clinicians paid
General and research payments are shown separately, never blended. Research payments are often institution-directed and tied to clinical trials.
General payments by year
General payments only, as reported to CMS. Research payments are totaled above and not included in these bars.
Products most associated with its payments
- Perla C $387K associated (2023-2025)
- Perla Tl $312K associated (2023-2025)
- Scarlet $57K associated (2023-2025)
- Scarlet Al-T $44K associated (2023-2025)
- Juliet Ll $33K associated (2023-2025)
- Cure Acp $8,377 associated (2023-2025)
- Perla Tl Mis $5,737 associated (2023-2025)
- Romeo Mis $5,500 associated (2023-2025)
- Talos $2,568 associated (2023-2025)
- Scarlet Ac-T $2,544 associated (2023-2025)
- Tryptik $2,500 associated (2023-2025)
- Baguera C $2,134 associated (2023-2025)
Specialties it works with most
Clinicians with the largest reported totals
Often long-running consulting, speaking, or advisory relationships, which companies must report by law. A large total is not evidence of anything improper.
| Clinician | Location | Specialty | General payments (2019-2025) |
|---|---|---|---|
| Joseph Laratta | Louisville, KY | Orthopaedic Surgery of The Spine | $295,419.75 |
| Jeremy Smith | Orange, CA | Orthopaedic Surgery of The Spine | $144,438.31 |
| Mudit Sharma | Manassas, VA | Neurological Surgery | $136,411.22 |
| Richard Meyrat | Dallas, TX | Neurological Surgery | $129,685.98 |
| Warren Yu | Washington, DC | Orthopaedic Surgery of The Spine | $120,633.83 |
| Rishi Wadhwa | Greenbrae, CA | Neurological Surgery | $116,592.08 |
| Joe Lee | Arcadia, CA | Orthopaedic Surgery of The Spine | $102,969.29 |
| Jason Liauw | Laguna Hills, CA | Neurological Surgery | $100,297.77 |
| Steven Spitz | Canton, GA | Neurological Surgery | $91,166.53 |
| Atul Patel | Fairfield, CA | Neurological Surgery | $90,600.72 |
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.